Correlation Between PaxMedica, Common and Virios Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PaxMedica, Common and Virios Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PaxMedica, Common and Virios Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PaxMedica, Common Stock and Virios Therapeutics Llc, you can compare the effects of market volatilities on PaxMedica, Common and Virios Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PaxMedica, Common with a short position of Virios Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PaxMedica, Common and Virios Therapeutics.

Diversification Opportunities for PaxMedica, Common and Virios Therapeutics

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between PaxMedica, and Virios is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding PaxMedica, Common Stock and Virios Therapeutics Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virios Therapeutics Llc and PaxMedica, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PaxMedica, Common Stock are associated (or correlated) with Virios Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virios Therapeutics Llc has no effect on the direction of PaxMedica, Common i.e., PaxMedica, Common and Virios Therapeutics go up and down completely randomly.

Pair Corralation between PaxMedica, Common and Virios Therapeutics

Given the investment horizon of 90 days PaxMedica, Common Stock is expected to under-perform the Virios Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, PaxMedica, Common Stock is 1.84 times less risky than Virios Therapeutics. The pink sheet trades about -0.18 of its potential returns per unit of risk. The Virios Therapeutics Llc is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  2,288  in Virios Therapeutics Llc on August 29, 2024 and sell it today you would lose (1,893) from holding Virios Therapeutics Llc or give up 82.74% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy14.67%
ValuesDaily Returns

PaxMedica, Common Stock  vs.  Virios Therapeutics Llc

 Performance 
       Timeline  
PaxMedica, Common Stock 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PaxMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, PaxMedica, Common is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Virios Therapeutics Llc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Virios Therapeutics Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly uncertain basic indicators, Virios Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

PaxMedica, Common and Virios Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PaxMedica, Common and Virios Therapeutics

The main advantage of trading using opposite PaxMedica, Common and Virios Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PaxMedica, Common position performs unexpectedly, Virios Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virios Therapeutics will offset losses from the drop in Virios Therapeutics' long position.
The idea behind PaxMedica, Common Stock and Virios Therapeutics Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites